InDevR

InDevR develops analytical testing solutions that help accelerate the development and manufacturing of vaccines. Its products and services support work with mRNA, protein-based, polysaccharide, conjugate, and viral vector vaccines, from research and development through clinical trials and product release.

The company’s VaxArray Platform uses microarray technology to combine multiple assays in a single test, delivering automated results in under two hours. Its portfolio includes the CypherOne System, VaxArray assays and kits for influenza, coronavirus, measles, rubella, pneumococcal disease, and poliovirus, as well as 5’CapQ and OmniFlu products. The platform can analyze antigens, antibodies, and oligonucleotides across a range of sample types and development stages. InDevR states that its software supports data integrity and security, including 21 CFR Part 11 compliance.

For specialized testing needs, InDevR’s Expert Services Team designs and develops custom assays. These services can help characterize proteins, assess serum antibody responses, analyze polysaccharides, and measure the identity and quantity of capped and intact mRNA constructs. The company’s solutions aim to improve testing speed, consistency, and data quality.